Saudi market index closes

TASI
10,326.47
+18.10 (+0.18%)
MT30
1,400.46
+2.64 (+0.19%)
NOMU (Capped)
22,054.14
+105.57 (+0.48%)
Sukuk
890.39
-0.62 (-0.07%)

Source: Saudi Exchange data supplied for this session. Not live prices.

GoFinsa

Welcome to GoFinsa!

ALHAMMADI

4007

GoFinsa Saudi Stock Investment Strength Index

78%
Investment strength
Explore the GoFinsa Saudi Stocks Index →

Analytical index, not a guaranteed return or buy recommendation.

22.44 SAR
Change: +0.46 SARChange %: +2.09 %Trading volume: 229,179 sharesTrades: 1,567 Open: 22.19 SARHigh: 22.48 SARLow: 21.93 SAR
Last available trade from session · 2026-11-12

ALHAMMADI stock (4007) price and technical analysis

GoFinsa tracks ALHAMMADI under symbol 4007, with the latest available price at 22.44 SAR. This page includes multi-timeframe charts, technical analysis and related market news.

Market data source: بيانات جلسة السوق السعودي المقدمة من المستخدم · Latest available update: 2026-11-12 · Delayed market data

Al Hammadi Stock (4007): Price, GoFinsa Rating and News

GoFinsa provides a guide to Al Hammadi stock, listed under ticker 4007, explaining its economic sector and factors that may help investors assess the stock.

About Al Hammadi and Its Business

Al Hammadi (ticker 4007) operates in the Saudi market and manufactures or distributes pharmaceutical products. The company description includes healthcare and pharmaceutical products among its areas of activity. This overview describes the nature of the business and its products; it does not mean that all listed activities contribute equally to revenue or that they have produced any particular financial results.

Al Hammadi Stock Information

Al Hammadi stock trades on the Saudi Exchange under ticker 4007 and belongs to the healthcare sector. Following official disclosures and financial results can help investors understand the company’s position and how its business is developing.

Al Hammadi’s Activities and Company Information

The company is classified in the healthcare sector of the Saudi market. Annual reports and official disclosures should be consulted to identify its activities, revenue sources and operational developments.

The Healthcare Sector in the Saudi Economy

The performance of listed healthcare companies can be affected by demand for their products and services, operating costs, competition, and economic and regulatory conditions. Each company’s exposure to these factors depends on its business model.

How to Read the Stock’s Financial Results

It is important to compare revenue, profit, cash flow and debt across multiple financial periods and to understand the reasons for changes rather than relying on a single quarter. Official announcements should also be reviewed for material events.

Factors That May Affect the Stock Price

Al Hammadi’s share price may be affected by company results and disclosures, trends in the Saudi market, interest rates and investor expectations. A change in the share price alone does not indicate an improvement in operating performance.

Investment Risks

Potential risks include share-price volatility, changes in costs, weak demand, competition and regulatory changes. The company’s actual risks depend on its activities and financial position.

The Stock’s Investment Strength According to the GoFinsa Saudi Stocks Index

The stock’s recorded rating in the GoFinsa GFSI is 80%. This is an independent analytical rating, not a guarantee of profit or a personal recommendation to buy.

Investing in Saudi Stocks

The Saudi Exchange includes companies in a range of economic sectors. Investors can benefit from reviewing disclosures, comparing financial valuations, diversifying risk and determining their investment horizon before making a decision.

Following Company News

The latest disclosures and news relating to Al Hammadi stock can be followed through the news sources and official data available on GoFinsa. Consider the date of each item and how directly it relates to the company.

Al Hammadi’s Reference Price

The recorded reference price is 22.61 SAR, dated 2026-10-08. This is a historical price, not a live quote or a confirmed price for current trading.

Al Hammadi’s Rating in the GoFinsa GFSI

The stock’s rating in the GoFinsa GFSI is 80%. This is a GoFinsa research rating, not a recommendation to buy or sell.

Overview of the Healthcare Sector

Al Hammadi stock belongs to the healthcare sector on the Saudi Exchange. Companies in the sector are affected by demand, competition, costs, and economic and regulatory conditions, while their risk profiles and revenue sources vary.

Trading Through XTB and Associated Risks

What Does Al Hammadi Do?

Al Hammadi (4007) belongs to the healthcare sector. The company’s candidate research scope includes operating hospitals and medical centers and providing treatment services. The precise details and any subsidiary activities should be checked against the company’s latest official profile before publication.

Where Does Al Hammadi’s Revenue Come From?

When analyzing Al Hammadi’s business model, review the following potential sources of income, subject to confirmation in the company’s financial statements: medical services revenue, patient visit volumes, occupancy and case mix. Listing these items does not mean that each is an actual contributor to the company’s revenue.

Factors That May Affect Al Hammadi’s Performance

Indicators relevant to monitoring Al Hammadi’s activities include occupancy rates, expansion, staffing costs and contracts with insurance companies. Compare actual trends in the company’s results over multiple periods, and do not infer growth or profitability without documented figures.

What to Check in the Annual Disclosure

When assessing Al Hammadi (4007), first identify the date of the latest annual report. Then review the description of its actual activities, operating segments and revenue-recognition policy. Read the financial statement notes rather than relying only on management’s summary; the notes may reveal obligations or events that are not apparent from the headline figures. Confirm the identity of the listed entity, its subsidiaries and the nature of their operations before attributing any activity or project to the company. Trends in the healthcare sector alone are not evidence that the company’s revenue is growing unless its published results support that conclusion.

How to Distinguish Real Growth from Accounting Changes

To analyze Al Hammadi, compare results for multiple periods of the same length and look for non-recurring items, reclassifications and changes in the consolidation scope. Higher revenue does not necessarily mean improved profitability if the cost of sales or expenses have risen faster. Review operating and net profit margins, then look in management’s commentary for explanations of the changes. If reliable, up-to-date financial statements are unavailable, these remain analytical steps rather than a description of Al Hammadi’s actual performance.

Cash Flow and the Ability to Fund Operations

When reviewing Al Hammadi’s data, it is useful to distinguish accounting profit from cash generated by operations. Examine net operating cash flow, changes in working capital, capital expenditure and financing costs. A company may report a profit while cash declines because of increases in receivables or inventory, or project payments. Conversely, cash flow may be temporarily affected by the timing of collections and payments. The company’s liquidity or solvency cannot be assessed without the relevant financial statements and notes.

Debt and Financing Costs: Key Questions

If Al Hammadi has financing obligations, start by identifying their maturities, the split between short- and long-term debt, borrowing costs and any contractual covenants. Assess how changes in interest rates could affect profits and cash flows, taking into account whether financing instruments have fixed or variable rates. The relevance of these questions depends on the company’s healthcare business model. This guide does not assume that the company has any particular level of debt or risk.

Comparing the Stock with Sector Peers Without Misleading Conclusions

For a fair comparison of Al Hammadi stock, select companies with similar activities, revenue mix, scale and regulatory context. Compare revenue growth, margins, return on capital and cash flows, and then account for differences in accounting and leverage. A lower price-to-earnings multiple than that of another company is not enough to conclude that the stock is cheaper; the difference may reflect growth expectations, risk or earnings quality. If a company reports losses or non-recurring profits, some valuation multiples may not be suitable for comparison.

How to Read the Reference Price and Its Date

The reference price shown in this guide is historical and dated; it is not a live bid or ask. When assessing Al Hammadi, check which trading session the price relates to and whether changes to capital, a share split or distributions may affect historical comparisons. Do not confuse the previous closing price with the latest trade or the session’s average price. If market data updates are delayed, its date should be displayed clearly, and no new daily trend should be inferred from an old figure.

Build Scenarios Instead of Forecasting a Specific Price

Three scenarios can be used to assess Al Hammadi: improving business conditions, conditions remaining unchanged, and a decline in demand or margins. For each scenario, define measurable assumptions, such as sales volume, input costs or financing expenses, and compare the resulting analysis with published financial statements when available. Do not set a price target without a valuation model and documented inputs, and do not present the positive scenario as an expected outcome. The aim is to understand how sensitive the investment is to new information.

Checklist Before Making an Investment Decision

Before investing in Al Hammadi stock, verify the ticker 4007, the company’s identity and the price date, and review the latest material disclosure, financial results and auditor’s notes, if available. Distinguish GoFinsa’s research rating from the suitability of the investment for your personal circumstances. Consider your investment horizon, ability to tolerate losses and exposure to the healthcare sector in your portfolio. Also review broker fees and the nature of the financial instrument: owning shares directly differs from trading derivatives or contracts for difference, which may involve additional risks.

أسئلة شائعة عن الشركة

What is Al Hammadi’s stock ticker?

The stock is listed on the Saudi Exchange under ticker 4007.

Which sector does Al Hammadi stock belong to?

The stock belongs to the healthcare sector.

Is the GoFinsa rating a recommendation to buy?

No. The rating is an analytical tool; it is not a personal investment recommendation or a guarantee of future performance.

Frequently asked questions about ALHAMMADI (4007)

What is the price of ALHAMMADI (4007)?

The latest price available in GoFinsa data is 22.44 SAR. Price status may be live or delayed depending on the market and data provider.

What does the technical analysis for ALHAMMADI (4007) show?

There is currently insufficient data to produce technical analysis for this instrument.

What is the GoFinsa.com General Index for ALHAMMADI?

The GoFinsa.com General Index is currently unavailable for this instrument.